Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUMIERE: Rose Bengal Photodynamic Therapy for Fusarium Keratitis
NCT07743489Phase 3Not yet recruiting
- Sponsor
- Stanford University
- Start
- Jan 2027
- Primary completion
- Apr 2029
- Countries
- 3
01
Overview
A Phase 3 trial of rose bengal in Fusarium keratitis, sponsored by Stanford University. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
rose bengal
03
Conditions
Fusarium keratitis
Beyond the preview
Go deeper on NCT07743489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07743489.